Publisher
Springer International Publishing
Reference36 articles.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet]. Lyon: International Agency for Research on Cancer; 2013. Available from:
http://globocan.iarc.fr
.
2. Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, et al. Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography. Ann Thorac Surg. 2016;101(1):226–30.
3. Pasquali S, Yim G, Vohra R, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265(3):481–91.
4. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002;359(9319):1727–33.
5. Cox SJ, O’Cathail SM, Coles B, Crosby T, Mukherjee S. Update on neoadjuvant regimens for patients with operable oesophageal/gastrooesophageal junction adenocarcinomas and squamous cell carcinomas. Curr Oncol Rep. 2017;19:7.